P. Jordens

Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma

G. Joos, M. Vaneechoutte, Dries Vaneechoutte, 2017, BMC Microbiology.

Pathogens in Early-Onset and Late-Onset Intensive Care Unit–Acquired Pneumonia

K. Verhamme, H. de Beenhouwer, W. D. De Coster, 2007, Infection Control & Hospital Epidemiology.

Characterisation of a collection of Streptococcus pneumoniae isolates from patients suffering from acute exacerbations of chronic bronchitis: in vitro susceptibility to antibiotics and biofilm formation in relation to antibiotic efflux and serotypes/serogroups.

G. Liistro, J. D'odemont, P. Tulkens, 2014, International journal of antimicrobial agents.

National guidelines for the judicious use of glycopeptides in Belgium.

M. Struelens, J. Maertens, B. Gordts, 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial

G. Verleden, V. Ninane, W. Janssens, 2019, Respiratory Research.

Azithromycin during Acute COPD Exacerbations Requiring Hospitalization (BACE): a Multicentre, Randomized, Double-blind, Placebo-controlled Trial.

G. Verleden, V. Ninane, W. Janssens, 2019, American journal of respiratory and critical care medicine.

AZITHROMYCIN DURING ACUTE CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS REQUIRING

G. Verleden, V. Ninane, W. Janssens, 2019 .

Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial

Johny Verschakelen, Geert Claeys, Ellen Deschepper, 2013, Thorax.

Chylothorax and chylous ascites due to malignant lymphoma.

P. Verstraeten, P. Jordens, L. Oosterbosch, 1995, Acta clinica Belgica.

Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma

G. Joos, M. Vaneechoutte, Dries Vaneechoutte, 2017, BMC Microbiology.

Characterisation of a collection of Streptococcus pneumoniae isolates from patients suffering from acute exacerbations of chronic bronchitis: in vitro susceptibility to antibiotics and biofilm formation in relation to antibiotic efflux and serotypes/serogroups.

P. Tulkens, F. Van Bambeke, P. Jordens, 2014, International journal of antimicrobial agents.

International Journal of Antimicrobial Agents Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates from Vaccinated and Non-vaccinated Patients with a Clinically Confirmed Diagnosis of Community-acquired Pneumonia in Belgium

P. Tulkens, J. Verhaegen, F. Jacobs, 2022 .